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Sec17 [soluble N-ethylmaleimide–sensitive factor (NSF) attachment
protein; α-SNAP] and Sec18 (NSF) perform ATP-dependent disas-
sembly of cis-SNARE complexes, liberating SNAREs for subsequent
assembly of trans-complexes for fusion. A mutant of Sec17, with
limited ability to stimulate Sec18, still strongly enhanced fusion
when ample Sec18 was supplied, suggesting that Sec17 has addi-
tional functions. We used fusion reactions where the four SNAREs
were initially separate, thus requiring no disassembly by Sec18.
With proteoliposomes bearing asymmetrically disposed SNAREs,
tethering and trans-SNARE pairing allowed slow fusion. Addition
of Sec17 did not affect the levels of trans-SNARE complex but
triggered sudden fusion of trans-SNARE paired proteoliposomes.
Sec18 did not substitute for Sec17 in triggering fusion, but ADP- or
ATPγS-bound Sec18 enhanced this Sec17 function. The extent of
the Sec17 effect varied with the lipid headgroup and fatty acyl
composition of the proteoliposomes. Two mutants further distin-
guished the two Sec17 functions: Sec17L291A,L292A did not stimulate
Sec18 to disassemble cis-SNARE complex but triggered the fusion
of trans-SNARE paired membranes. Sec17F21S,M22S, with dimin-
ished apolar character to its hydrophobic loop, fully supported
Sec18-mediated SNARE complex disassembly but had lost the
capacity to stimulate the fusion of trans-SNARE paired mem-
branes. To model the interactions of SNARE-bound Sec17 with
membranes, we show that Sec17, but not Sec17F21S,M22S, inter-
acted synergistically with the soluble SNARE domains to enable
their stable association with liposomes. We propose a model in
which Sec17 binds to trans-SNARE complexes, oligomerizes, and
inserts apolar loops into the apposed membranes, locally disturb-
ing the lipid bilayer and thereby lowering the energy barrier
for fusion.
membrane fusion | SNAREs | α-SNAP | NSF
Intracellular vesicular traffic between organelles is the basis ofcell growth, hormone secretion, and neurotransmission. At each
step of exocytic and endocytic trafficking, membranes dock and
fuse, mixing their lipids and luminal contents while keeping them
separate from the cytosol. Families of proteins, conserved from
yeast to humans, mediate docking and fusion. Fusion requires Rab
family GTPases and “effector” proteins that bind to a Rab in its
active, GTP-bound state (1). Among the effectors are large,
organelle-specific tethering complexes. Fusion requires SNARE
proteins and their chaperones. SNAREs (2) are proteins that can
“snare” (bind to) each other, in cis (when anchored to the same
membrane) or in trans (when anchored to apposed, tethered
membranes). SNAREs have a conserved “SNARE domain” with
a characteristic heptad repeat. SNAREs are categorized as
R-SNAREs if they have a central arginyl residue, or Qa-, Qb-, or
Qc-SNAREs with a central glutamyl residue (3). SNAREs form
RQaQbQc quaternary cis- or trans-SNARE complexes, which
bind SNARE chaperones, including the Sec1/Munc18 family of
SNARE binding proteins, and Sec18/NSF (N-ethylmaleimide–
sensitive factor), an AAA family ATPase that drives SNARE
complex disassembly (4). Sec17/α-SNAP (soluble NSF attach-
ment protein) is a cochaperone to Sec18 that enhances its rate of
SNARE complex disassembly (5).
We study fusion with yeast vacuoles. The homotypic fusion of
vacuoles has been studied extensively through genetic identifica-
tion of vacuole morphology (vam) mutants (6) and vacuole pro-
tein sorting (vps) mutants (7), through a colorimetric assay of the
fusion of isolated vacuoles (8), and more recently through the
fusion of proteoliposomes reconstituted with defined, purified
proteins and lipids (9–11). Sec17, Sec18, and ATP catalyze the
first stage of vacuole fusion, in which cis-SNARE complexes are
disassembled (12). Tethering is then supported by the Rab Ypt7
and the large, multisubunit tethering complex termed HOPS (13).
Vps33, one of the HOPS subunits, is the vacuolar SM (Sec1/
mUNC-18 family) protein. HOPS has direct affinity for vacuolar
SNAREs (14–16), and helps to catalyze SNARE complex as-
sembly and the subsequent fusion (17).
During in vitro fusion incubations, most Sec17 is released from
vacuoles during cis-SNARE complex disassembly (12). However, a
few percent of the vacuolar SNAREs form trans-SNARE com-
plexes (18), and Sec17 is a major constituent of these complexes
(19). Furthermore, although Sec17 and Sec18 can disassemble
trans-SNARE complexes (19) and will block fusion events in which
tethering is supplied by an unphysiological agent such as poly-
ethylene glycol (13), Sec17 and Sec18 work synergistically with
HOPS to promote fusion (9, 20). This synergy is even seen when
the SNAREs are initially disposed with the R-SNARE on one set
of proteoliposomes and the three Q-SNAREs on the others (9), a
condition that per se does not require cis-SNARE complex disas-
sembly by Sec18. Finally, added Sec17 restores fusion to vacuoles
where fusion is blocked by a defined C-terminal truncation in the
SNARE domain of the Qc-SNARE Vam7, in the apparent ab-
sence of ATP or Sec18 activity (21). These observations prompted
us to reevaluate the roles of Sec17 and Sec18 in the fusion pathway.
Significance
Intracellular membrane trafficking relies on SNARE proteins from
apposed membranes to form trans-complexes. Sec18 (N-ethyl-
maleimide–sensitive factor; NSF) and its cochaperone Sec17
(soluble NSF attachment protein; α-SNAP) disassemble cis-SNARE
complexes, liberating SNAREs for trans-complex assembly. We
now describe an additional function of Sec17, its ability to trig-
ger the fusion of trans-SNARE paired membranes. We propose a
model in which Sec17 oligomerizes on trans-SNARE complexes,
inserting apolar loops into the adjacent membranes. This pre-
cisely localized membrane interaction may disturb the lipid bi-
layer, lowering the energy barrier that prevents the two
membranes from merging, and thereby facilitate fusion.
Author contributions: M.Z., A.O., M.L.S., A.J.M., andW.T.W. designed research; M.Z., A.O.,
M.L.S., and W.T.W. performed research; M.L.S. and A.J.M. contributed new reagents/
analytic tools; M.Z., A.O., and W.T.W. analyzed data; and M.Z. and W.T.W. wrote
the paper.
Reviewers: J.R., UT Southwestern; and R.S., University of California, Berkeley.
The authors declare no conflict of interest.
1To whom correspondence may be addressed. Email: michael.zick@dartmouth.edu or bill.
wickner@dartmouth.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1506409112/-/DCSupplemental.
E2290–E2297 | PNAS | Published online April 20, 2015 www.pnas.org/cgi/doi/10.1073/pnas.1506409112
We now exploit proteoliposomes bearing purified vacuolar
Rab and SNAREs to reinvestigate the roles of Sec17 and Sec18.
Generous amounts of Sec18 alone can disassemble cis-SNARE
complexes, allowing proteoliposomes bearing all four vacuolar
SNAREs to fuse at a moderate rate. The rate of fusion can be
stimulated by wild-type Sec17, as expected, but also by a Sec17
mutant that has greatly diminished capacity to stimulate Sec18.
This suggested that Sec17 could act in ways other than through
Sec18 stimulation. We therefore examined fusion incubations
where the SNAREs are disposed on complementary proteoli-
posomes such that Sec18 is not required at all. We find that
Sec17 can trigger rapid fusion of proteoliposomes that are al-
ready joined by trans-SNARE associations.
Results
Sec17 and Sec18 disassemble cis-SNARE complexes so that
SNAREs can associate in trans (12, 22). We used our recon-
stituted reaction of proteoliposome fusion with defined proteins
and lipids (9–11) to examine whether Sec17 and Sec18 have sep-
arable activities. Sec18, at high levels, promoted a slow fusion
reaction without Sec17 (Fig. 1A and Fig. 1B, first column)
whereas, as expected, Sec17 alone did not support fusion when the
SNARES are in cis-complex (Fig. 1B, row a). With 10 nM Sec18,
fusion strictly required Sec17. Sec17L291A,L292A, modeled on an
α-SNAP mutation that does not stimulate NSF (5, 21), did not
suffice (Fig. 1B, row b). Higher levels of Sec17 inhibited fusion,
as noted in earlier studies of fusion of the intact organelle (23).
With higher Sec18 concentrations (Fig. 1B, rows c and d),
Sec17L291A,L292A stimulated Sec18-dependent fusion. With 100 nM
Sec18, the fusion seen with 64 nM Sec17L291A,L292A was compa-
rable to that seen with 2 nM wild-type Sec17 (Fig. 1B, c3 and c8),
suggesting that Sec17L291A,L292A is about 1/32 as active as wild-type
Sec17. However, with 10 nM Sec18, there was far more fusion
with, for example, 8 nM Sec17 than with 256 nM Sec17L291A,L292A
(Fig. 1B, b5 and b10). It was thus difficult to fully explain the
observed pattern by considering Sec17 only as a cofactor to
Sec18. An alternative explanation was that Sec17 fulfills a second
function. To seek this function, we sought fusion conditions
where Sec17 could be tested in the absence of Sec18.
Sec17 Can Function Without Sec18. To remove the requirement for
Sec18, we sought conditions where the SNAREs in a fusion in-
cubation were not initially in complex with each other. Although
the Qb-SNARE Vti1 has a C-terminal transmembrane anchor,
we have reported (17) that fusion does not depend on this anchor.
When vacuolar mixed lipid (VML) proteoliposomes with 18:2
fatty acyl composition and bearing Ypt7–GTP and the R-SNARE
Nyv1 were mixed with proteoliposomes with Ypt7–GTP and the
Qa-SNARE Vam3, fusion could be triggered by the addition of a
mixture of HOPS, soluble Vti1 lacking its membrane anchor
(termed sVti1), and the inherently soluble Qc-SNARE Vam7
(Fig. 2A). The four SNAREs were separate from each other when
they were introduced into these fusion incubations, that is, there
were no cis-SNARE complexes to disassemble and therefore the
reaction did not require Sec18 or ATP. This fusion reaction (Fig.
2A) showed a modest but consistent stimulation by Sec17, until by
6.4 μΜ the stimulation was overcome by the inhibitory effect of
Sec17, as noted before. To optimize the stimulation by Sec17, we
varied the lipid composition of the proteoliposomes. We have
recently reported that acidic lipids (24) and small-headgroup

































Sec17 WT Sec17 L291A L292A
a1 a2 a3 a4 a5 a6 a7 a8 a9 a10 a11 a12
b1 b2 b3 b4 b5 b6 b7 b8 b9 b10 b11 b12
c1 c2 c3 c4 c5 c6 c7 c8 c9 c10 c11 c12






























Fig. 1. Mutant Sec17 that is defective in stimulating Sec18 ATPase activity is still able to stimulate four-SNARE–four-SNARE fusion reactions. (A) Fusion
reactions contained RPLs of vacuolar mixed lipids (18:2) and the four vacuolar SNAREs at a 1:1,000 protein:lipid ratio. Reactions were initiated by addition of
50 nM HOPS, 1 mM ATP (unless specified otherwise), and increasing concentrations of Sec18. (B) Four-SNARE fusion reactions as in Awere initiated with 50 nM
HOPS, 1 mM ATP, increasing concentrations of Sec18 (Top to Bottom rows), and increasing concentrations of Sec17 (Left to Right columns). The added Sec17
was either the wild-type version (WT; blue curves) or a version that carries mutations that impair Sec17 stimulation of Sec18 (L291A and L292A; orange
curves). The x axis represents 0–30 min, and the y axis represents 0–80% content mixing. Kinetic curves of content mixing assays in this and subsequent figures
are representative of n ≥ 3 experiments.














Proteoliposomes of only PC and PS were less active than those of
vacuolar lipid composition but were strongly stimulated by the
addition of Sec17 (Fig. 2B) in the absence of Sec18 or ATP.
Sec17L291A,L292A was just as active as wild-type Sec17 in stimu-
lating this Sec18-independent fusion (Fig. 2C), in marked contrast
to its diminished capacity to support Sec18-dependent fusion (Fig.
1B, row b). Fusion of similar proteoliposomes with a vacuolar lipid
composition but with fatty acyl chains 16:0 and 18:1 also required
added Sec17 (Fig. 2D). Thus, both lipid headgroup and fatty acyl
compositions strongly affected the degree to which fusion required
added Sec17.
Sec17 Stimulates Fusion After trans-SNARE Pairing. It has been
suggested that fusion is largely regulated through controlling trans-
SNARE pairing (26). However, tethering factors and nonbilayer-
prone lipids are essential for fusion beyond modulating the level of
trans-SNARE pairing (20, 25). We therefore assayed both fusion
and trans-SNARE pairing between proteoliposomes bearing Ypt7–
GTP and the R-SNARE Nyv1 and those with Ypt7–GTP and the
Qa-SNARE Vam3. Fusion was initiated in duplicate incubations
by the addition of soluble protein mixtures, either sVti1, Vam7,
HOPS, and Sec17 (Fig. 3A, sample b) or this mixture with each of
these proteins singly omitted (samples a and c–f). Fusion required
each of these soluble proteins, including Sec17 (Fig. 3A, Left).
After 2 min of incubation, one of each of the duplicate incubations
was solubilized with detergent and assayed for Nyv1 that was as-
sociated with Vam3 by immunoprecipitation with immobilized
antibody to Vam3 and immunoblot for Nyv1 (Fig. 3A, Right). For
one sample, which initially did not have Vam7, Vam7 was added
with the detergent (sample e). Although Sec17 was essential for
fusion (Fig. 3A, Left), the presence or absence of Sec17 had little
effect on the level of trans-SNARE complex (Fig. 3A, Right, a vs. b).
The trans-SNARE complex that had formed in the absence of
Sec17 was not somehow defective, because addition of Sec17 after
10 min triggered a dramatic burst of fusion at a rate that increased
with Sec17 concentration (Fig. 3B). High concentrations of Sec17
that were present from the start of the incubation inhibited fusion
























































































































Fig. 2. Sec17 can stimulate fusion reactions without Sec18. (A) Fusion re-
actions had a mixture of RPLs of VMLs (18:2) bearing either the R-SNARE
Nyv1 (1:10,000 protein:lipid ratio) or the Qa-SNARE Vam3 (1:2,000 protein:lipid
ratio). The Qb-SNARE Vti1 without its transmembrane domain (500 nM) and
the Qc-SNARE Vam7 (50 nM) were added, and fusion was initiated by adding
50 nM HOPS and increasing amounts of Sec17. (B) Reactions as in A, but with
RPLs composed of PC/PS (18:2) lipids. (C) Reactions as in B, but with a mutant
version of Sec17 (L291A and L292A). (D) Reactions as in A, but with RPLs




Fig. 3. Sec17 triggers fusion of trans-SNARE paired membranes. (A) Fusion
reactions had RPLs of PC/PS (18:2) lipids bearing either the R-SNARE Nyv1
(1:2,500 protein:lipid ratio) or the Qa-SNARE Vam3 (1:2,500 protein:lipid
ratio). The reactions (a–f) were started by adding 636 nM soluble version of
the Qb-SNARE Vti1, 304 nM Qc-SNARE Vam7, 66 nM HOPS, and 1 μM Sec17,
or their respective buffers. After 2 min, parallel incubations were lysed in
detergent and subjected to immunoprecipitation with anti-Vam3 anti-
bodies. For sample e, Vam7 was added to the detergent lysate before im-
munoprecipitation. All samples were analyzed by SDS/PAGE and Western
blotting with anti-Nyv1 antibodies, reflecting the amount of Vam3–Nyv1
trans-interactions. (B) Fusion reactions had RPLs composed of PC/PS (18:2)
lipids bearing either the R-SNARE Nyv1 (1:10,000 protein:lipid ratio) or the
Qa-SNARE Vam3 (1:2,000 protein:lipid ratio). A soluble version of the Qb-
SNARE Vti1 (500 nM) and the Qc-SNARE Vam7 (50 nM) were added, and the
reactions were initiated by addition of 50 nM HOPS. After 10 min, the in-
dicated concentrations of Sec17 were added. (C) Fusion reactions as in B, but
the indicated concentrations of Sec17 were added with HOPS at t = 0 min.
(D) Similar fusion reactions as in B, but sVti1 (500 nM), Qc (50 nM), and HOPS
(50 nM) were either all added at t = 0 min or withheld individually and only
added at t = 10 min. Sec17 (10 μM) was added at t = 10 min. (E and F) Fusion
reactions as in B, but without HOPS and with higher concentrations of the
soluble SNAREs sVti1 (0–4 μM) and Vam7 (0–4 μM). The soluble SNAREs were
added at t = 0 min either without a tethering agent (E) or with 2% (wt/vol)
PEG 8000 (F) as a chemical tether. Sec17 (10 μM) was added at t = 10 min.
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Sec17 addition to preformed SNARE complexes showed no such
inhibition (Fig. 3B). The burst of fusion seen upon addition of Sec17
after 10 min of incubation relied on preformed trans-SNARE
complex, as shown by its dependence on the presence of Vam7,
sVti1, and HOPS during the initial incubation period (Fig. 3D).
Although HOPS and Ypt7 were optimal for tethering, the artificial
tethering agent polyethylene glycol (PEG) could also support the
generation of a fusion-competent state. This reaction was also de-
pendent on the soluble SNAREs, although at higher concentration,
and was triggered by Sec17 addition (Fig. 3 E and F).
Might the capacity of Sec17 to trigger the fusion of proteoli-
posomes with trans-SNARE complexes be limited to reactions
with sVti1, lacking its physiological transmembrane domain?
Proteoliposomes that bore Ypt7–GTP and either the R-SNARE
Nyv1 or the Qa- and Qb-SNAREs Vam3 and full-length Vti1 were
mixed with HOPS and Vam7. As reported (9, 17), fusion did not
require Sec17 or Sec18. However, the addition of Sec17 after
10 min triggered a concentration-dependent burst of fusion (Fig.
4A). Thus, although the C-terminal truncation of Vti1 may en-
hance the effect, Sec17 also triggered fusion when wild-type
SNAREs were disposed such that SNARE complex disassembly
was not required. Under these conditions, rapid SNARE complex
assembly was followed by slow fusion without Sec17. Sec17 also
triggered rapid fusion between proteoliposomes bearing all three
Q-SNAREs and those bearing the R-SNARE (Fig. 4B). Whereas
8 or 32 μM Sec17 was able to trigger a rapid burst of fusion, the
inhibition at intermediate levels of Sec17 (2 μM) was presumably
due to the inhibition of further trans-SNARE complex formation
(as in Fig. 3 B–D) without triggering a substantial burst of fusion
first. These findings were similar to observations with intact vac-
uoles, where docking occurs ∼20 min before fusion (12, 27).
Without ATP Hydrolysis, Sec18 Enhances the Sec17 Fusion Trigger.
Can Sec18 affect the capacity of Sec17 to trigger fusion of
trans-SNARE paired proteoliposomes? Mixed proteoliposomes
bearing Ypt7–GTP and either Nyv1 or Vam3 were incubated
with sVti1, Vam7, and HOPS for 10 min and then mixed with
50 nM Sec17, a concentration where it has little effect on the rate
of fusion (Figs. 3B and 5A). Supplementation of the Sec17 with
up to 640 nM Sec18 and ATP had little effect (Fig. 5A). How-
ever, supplementation with Sec18 + ADP (Fig. 5B) or Sec18 +
ATPγS (Fig. 5C) gave a strong stimulation that remained fully
dependent on Sec17 (Fig. 5D). Sec18 cannot disassemble SNARE
complexes with ADP or ATPγS, but the affinities of Sec18 for
both SNAREs and Sec17 may facilitate their association at low
Sec17 levels.
Importance of the Apolar Loop of Sec17. The N-terminal apolar
loop of Sec17 (28), residues 19–30, might stimulate fusion through
bilayer penetration. A recent structure of the 20S supercomplex
(29), which was determined by single-particle electron cryomicro-
scopy, has shown that this loop is poised next to the SNARE
transmembrane segments when Sec17 oligomers are in complex
with a four-helical SNARE bundle, which might be envisioned as a
cis-SNARE complex (29) or as a trans-SNARE complex (Fig. 6A).
Proteoliposomes of full vacuolar lipid mix, Ypt7–GTP, and the four
SNAREs did not fuse when given only 10 nM Sec18 (Fig. 1B, row b
and Fig. 6B, b1) unless they were also supplied with Sec17 (b2–b6,
blue curves). Substitution of polar residues for hydrophobic resi-
dues within the loop by mutations F21S and M22S had almost no
effect under Sec18-dependent fusion conditions (Fig. 6B, orange
curves). However, in incubations with PC/PS proteoliposomes
bearing Ypt7–GTP and either the R-SNARE Nyv1 or the Qa-
SNARE Vam3, supplemented with sVti1, Vam7, and HOPS,
Sec17F21SM22S could not trigger a burst of fusion (Fig. 6C, orange
curves). The two activities of Sec17 were thus distinguished in three
manners: by assays that exclusively require the SNARE complex
disassembly function or the fusion-triggering function; through
Sec17 mutants that are selectively disabled for each of these func-
tions; and by their exclusive cooperation with either Sec18–ATP
or Sec18–ADP.
For another model of these interactions, we incubated lipo-
somes of PC/PS with Sec17 or Sec17F21S,M22S and the mixed
recombinant vacuole SNAREs lacking their transmembrane do-
mains, termed sSNAREs (soluble SNAREs). After incubation,
liposomes were reisolated by flotation and assayed for bound
proteins (Fig. 7). When the sSNAREs and Sec17 were coincu-
bated with liposomes, they each floated (Fig. 7A, lane b), whereas
Sec17 alone or sSNAREs alone showed much less association
with liposomes (lanes a and c). Sec17 is known to oligomerize
upon association with SNAREs (29–31), which may multiply its
affinity for lipids. Incubations of soluble SNARE domains and
Sec17F21S,M22S, deficient in the apolar character of its loop do-
main, showed little association of either the sSNAREs or mutated
Sec17 with the liposomes beyond the backgrounds seen in sepa-
rate incubations (Fig. 7A, lane d vs. lanes a and e).
Discussion
Sec17/α-SNAP, which stimulates SNARE complex disassembly
by Sec18/NSF, can drive rapid fusion of proteoliposomes that
have already formed trans-SNARE pairs. These two activities of
Sec17 are distinguished in four ways. (i) Four-SNARE proteo-
liposomes rely on Sec18 for cis-SNARE complex disassembly
(Fig. 1), whereas fusion reactions without cis-SNARE complexes
A
B
Fig. 4. Sec17 can stimulate fusion reactions with all wild-type SNAREs.
(A) Fusion reactions had RPLs composed of PC/PS (18:2) lipids bearing either
the R-SNARE Nyv1 (1:10,000 protein:lipid ratio) or both the Qa-SNARE Vam3
and the Qb-SNARE Vti1 (1:10,000 protein:lipid ratio). The Qc-SNARE Vam7
(50 nM) was added, and tethering was initiated by addition of 50 nM HOPS.
After 10 min the indicated amounts of Sec17 were added. (B) Fusion re-
actions had RPLs composed of VMLs (16:0 18:1) bearing either the R-SNARE
Nyv1 (1:1,000 protein:lipid ratio) or the three Q-SNAREs Vam3, Vti1, and
Vam7 (1:1,000 protein:lipid ratio). The RPLs were mixed and incubated for
10 min before 50 nM HOPS was added. After 2 min, the indicated amounts
of Sec17 were added.














are stimulated by Sec17 without Sec18 being required (Fig. 2).
(ii) Sec17- and Sec18-mediated disassembly of cis-SNARE com-
plexes requires ATP, whereas Sec18 only stimulates Sec17 to
trigger fusion when it is complexed with ADP or ATPγS (Fig. 5).
(iii) The fatty acyl composition has a marked effect on the de-
pendence of fusion on Sec17 (Fig. 2). (iv) Mutations in the apolar
loop of Sec17 near its N terminus prevent it from triggering fusion
while allowing it to cooperate with Sec18 for disassembly of cis-
SNARE complexes (Fig. 6), whereas mutations in a C-terminal
region have the opposite effect, blocking stimulation of Sec18 (Fig.
1B) while still triggering trans-SNARE paired proteoliposomes to
fuse (Fig. 2C). In sum, it is clear that Sec17 can have two very
distinct roles in fusion.
These and other recent findings suggest a revised working
model of vacuole homotypic fusion. cis-SNARE complexes are





Fig. 5. ADP- or ATPγS-bound Sec18 enhances Sec17-triggered fusion. (A–C)
Fusion reactions contained RPLs of PC/PS (18:2) lipids bearing either the
R-SNARE Nyv1 (1:10,000 protein:lipid ratio) or the Qa-SNARE Vam3 (1:2,000
protein:lipid ratio). A soluble version of the Qb-SNARE Vti1 (500 nM) and the
Qc-SNARE Vam7 (50 nM) were added, and the reaction was initiated by
addition of 50 nM HOPS. After 10 min, 50 nM Sec17, the indicated amounts
of Sec18, and either 1 mM ATP (A), 1 mM ADP (B), or 1 mM ATPγS (C) were
added. (D) The same reactions as in A–C with 640 nM Sec18 are shown for




Fig. 6. Hydrophobic loop of Sec17 is critical for its fusion trigger function.
(A) Model of Sec17 fusion trigger action, based on the structure of the 20S
complex (29) modeled to trans-SNARE interactions. (B) Fusion reactions
contained RPLs of VMLs (18:2) and the four vacuolar SNAREs at a 1:1,000
protein:lipid ratio. Reactions were initiated by addition of 50 nM HOPS,
1 mM ATP, 10 nM Sec18, and Sec17. The added Sec17 was either the wild-
type version (blue curves) or a version that carries mutations in an N-terminal
hydrophobic loop of Sec17 (F21S and M22S; orange curves). The x axis repre-
sents 0–30 min, and the y axis represents 0–80% content mixing. (C) Fusion
reactions contained RPLs of PC/PS (18:2) lipids bearing either the R-SNARE Nyv1
(1:10,000 protein:lipid ratio) or the Qa-SNARE Vam3 (1:2,000 protein:lipid ra-
tio), a soluble version of the Qb-SNARE Vti1 (500 nM), and the Qc-SNARE Vam7
(50 nM). Reactions were initiated by addition of 50 nM HOPS. After 10 min,
either wild-type Sec17 (blue curves) or a version that carries mutations in an
N-terminal hydrophobic loop (F21S and M22S; orange curves) was added. The
x axis represents 0–30 min, and the y axis represents 0–80% content mixing.
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Sec17. HOPS then tethers the membranes (13) through its affin-
ities for Ypt7–GTP on each membrane (32) and for acidic lipid
(24). Tethered membranes become drawn against each other, and
the proteins and lipids needed for fusion become enriched in an
interdependent manner in a ring-shaped microdomain surround-
ing the two apposed membranes (33, 34). HOPS catalyzes the
entry of the soluble Vam7 Qc-SNARE into trans-SNARE com-
plexes (17), and may protect the trans-SNARE complex from
Sec18-mediated disassembly (19) in a manner that requires its
Vps33 subunit (35).
Recent studies have clarified the elements that allow docked
membranes with SNAREs paired in trans to proceed to fuse. At
unphysiologically high SNARE levels, multiple trans-SNARE com-
plexes alone drive a very slow fusion (20). Even with trans-SNARE
pairing linking apposed membranes, the rate of fusion is strongly
enhanced by the presence of a tether, whether the physiological
Ypt7–HOPS tether or a synthetic tether such as polyethylene glycol
(17). In either case, small-headgroup lipids, which lower the energy
for membrane transitions through nonbilayer intermediates, are re-
quired for meaningful fusion rates (25). We now report that Sec17
can dramatically accelerate fusion once trans-SNARE pairs have
assembled. The concentrations at which these effects were observed
were in the range of the cytosolic concentration of Sec17, which can
be estimated as 0.5–1.5 μM, based on proteome quantification
studies indicating Sec17 abundance at 65–205 parts per million (36,
37) and a cellular protein concentration of 280 mg/mL (38). Vacuole
fusion experiments with Vam73Δ, a truncation mutant of Vam7 (21),
support this interpretation. In these studies, Vam73Δ formed trans-
SNARE complexes as efficiently as wild-type Vam7. The partially
zipped complexes did not drive fusion but were rescued by Sec17
in the absence of ATP. Enhanced proteoliposome fusion due to
Sec17 is lost in the Sec17F21S,M22S mutant, and thus likely depends
on the hydrophobicity of the Sec17 19–30 loop region. The
structure of the 20S Sec18–Sec17–SNARE complex (29) shows
that Sec17 oligomerizes when bound to SNAREs and that each of
the several Sec17 apolar loops is poised near the SNARE mem-
brane anchors, where it may insert into a bilayer. In accord with
this concept, Sec17 and the mixed soluble domains of the vacuolar
SNAREs are interdependent for a lipid association that can
withstand flotation (Fig. 7). Sec18–ADP may enhance binding of
Sec17 to the trans-SNARE complex but only exchange the ADP
for ATP and catalyze SNARE complex disassembly after fusion
has converted the trans complex to cis. Alternatively, Sec18–ATP
may not be able to bind to a HOPS–Sec17–trans-SNARE complex
at all. It is also unclear whether Sec17 displaces HOPS from
SNARE complexes (39) before fusion.
Fusion, and its dependence on Sec17, is regulated by mem-
brane lipid composition. With vacuolar lipid mix and 18:2 fatty
acyl chains there is only minimal effect of Sec17 in enhancing
fusion, whereas with PC/PS and 18:2 the effect is striking (Fig. 2 A
and B). However, with 16:0 18:1 fatty acyl chains, fusion of even
VML proteoliposomes is strongly stimulated by added Sec17 (Fig.
2D). In the context of the complex physiological fatty acyl and
headgroup composition of yeast vacuolar lipids (40, 41), further
studies will be needed to define the common denominator for the
lipid role in this reaction.
Several factors can contribute to lowering the energy barrier
for two apposed membranes to rearrange their bilayers for fusion:
(i) the physical force of membrane deformation deriving from
trans-SNARE complexes forming continuous α-helices between
their SNARE and transmembrane domains (42) [the initial con-
cept that the energy for fusion derives entirely from forming a
continuous α-helix between SNARE and transmembrane domains
has been questioned by observations that transmembrane domains
can be replaced by lipidic anchors for yeast vacuole fusion (43) or
neuronal fusion (44)]; (ii) the docking of membranes in close
proximity (45, 46); (iii) the membrane bending that surrounds
an extended region of membrane contact, driven by tethers (47);
(iv) the enrichment of small headgroup lipids that can more
readily fit into the nonbilayer lipidic structures of hemifusion and
fusion intermediate states (25, 34); and (v) localized (e.g., trans-
SNARE–associated) additional proteins or other factors that can
bind to lipids or insert into membranes to promote nonbilayer
transitions. The latter includes Ca2+-triggered insertion of syn-
aptotagmin at the neuronal synapse (48) and Sec17 for intracellular
fusion. In model systems, transition from apposed bilayers to fusion
has even been promoted by interaction of calcium with lipids (49).
The relative contribution of each to achieving the activation state
for transition to fusion remains for future biophysical studies; im-
portant progress has been made in this regard with SNAREs (50).
We have reported (12) that Sec17 is released from vacuoles by
the ATP-dependent action of Sec18, and that subsequent fusion
becomes insensitive to antibodies to Sec17. How can this be ratio-
nalized with our current findings? Only a few percent of SNAREs
become engaged in trans (18), and only a correspondingly small
fraction of the initially bound Sec17 may be needed to trigger fu-
sion. Because the fusion of docked vacuoles is slow in vitro, oc-
curring with a half-time of 20 min or more (27), these kinetics may
not depend on Sec17. It is possible that the stimulation we report
here may or may not be necessary in all physiological conditions.
Our observations reveal more about what can potentially contribute
to fusion rather than providing evidence of whether Sec17 physio-
logically fulfills this function. Nonetheless, the finding that fusion
arrested by a C-terminal deletion in the Vam7 SNARE domain (21)
A
B
Fig. 7. Mutation of the hydrophobic loop of Sec17 results in reduced
membrane association. Liposomes were incubated with a mixture of sSNAREs
and Sec17, WT, or bearing mutations F21S and M22S, as indicated, for 1 h and
subjected to flotation on a density gradient (see Methods for details). The
recovered liposome samples were analyzed by SDS/PAGE and Western
blot. (A) Representative Western blots of proteins that floated with lipo-
somes. (B) Quantification of Western blot analysis, as in A, from three
independent experiments. Different exposures, most suitable to relate
individual signals to the corresponding range of the standard curves, were
used. The signal intensities of condition b (with sSNAREs and Sec17 WT)
were normalized to 100%. The primary quantification data (averages and
SDs) are listed in Table S1.














can be rescued by added Sec17 shows that this effect can occur on
the native organelle.
The triggering of a burst of fusion by Sec17 may share im-
portant mechanistic features with synaptotagmin and Ca2+-trig-
gered fusion. In each case, a protein associates with SNAREs and
inserts a domain into the bilayer, providing the impetus for rapid
transition to fusion. In neither case is there an absolute fusion
dependence on the SNARE-bound, membrane-inserting protein.
Synaptotagmin/Ca2+-independent fusion events are seen at the
synapse (51), as fusion in the reconstituted yeast vacuolar system
can occur independent of Sec17 (9, 17, 52). Because synaptic
vesicle fusion also involves SNAPs, the neuronal homologs of
Sec17, it is even conceivable that synaptotagmin and SNAPs could
cooperate to trigger fast fusion in this system.
Methods
Proteins and Reagents. Lipids were obtained fromAvanti Polar Lipids, with the
exception that ergosterol was from Sigma-Aldrich, PI(3)P was from Echelon
Biosciences, and the fluorescent lipids [Marina Blue-DHPE (1,2-dihexadecanoyl-
sn-glycero-3-phosphoethanolamine), NBD (nitrobenzoxadiazole)-DHPE] were
from Life Technologies. Biotinylated R-phycoerythrin was purchased from Life
Technologies, Cy5-derivatized streptavidin was from KPL, and unlabeled
streptavidin was from Thermo Scientific. Sec18 (53), Sec17 and Sec17L291A,L292A
(21), Ypt7 (17), HOPS (17), and vacuolar SNARE proteins (9, 11, 21) were pu-
rified as described. The Sec17F21S,M22S construct was created by site-directed
mutagenesis and purified as for the other Sec17 constructs. Soluble Vti1 (sQb)
was purified as MBP-TEV-Vti1(1–194) as described (17).
Reconstitution of Vacuolar Rab/SNARE Proteoliposomes. Proteoliposomes
bearing Cy5-streptavidin or biotinylated R-phycoerythrin were prepared from
mixed micellar solutions (containing 50 mM β-octyl-glucoside) by detergent di-
alysis (20-kDa cutoff membrane) in RB150/Mg2+ [20 mM Hepes·NaOH, pH 7.4,
150 mM NaCl, 1 mM MgCl2, 10% glycerol (vol/vol)] as described (17), with
modifications. Lipids dissolved in chloroform were mixed at the following
proportions: For vacuolar mixed lipids (16:0 18:1), 44.6–47.6 mol% POPC (1-pal-
mitoyl-2-oleoyl-sn-glycero-3-phosphocholine), 18 mol% POPE (1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphoethanolamine), 18 mol% soy PI (L-α-phosphatidyli-
nositol), 4.4 mol% POPS (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine), 2
mol% POPA (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate), 1 mol% 16:0 DAG
(1,2-dipalmitoyl-sn-glycerol), 8 mol% ergosterol, and 1 mol% PI(3)P [1,2-dipal-
mitoyl-sn-glycero-3-phospho-(1′-myo-inositol-3′-phosphate)]. For VMLs (18:2),
lipids were used in the same proportions as above, but with the dilinoleoyl
forms of PC, PE, PS, and PA. For PC/PS (18:2), 66–68.8 mol% DLPC (1,2-dilino-
leoyl-sn-glycero-3-phosphocholine), 30 mol% DLPS (1,2-dilinoleoyl-sn-glycero-
3-phospho-L-serine), and 1 mol% PI(3)P. Fluorescent lipids (0.2 mol% Marina
Blue-DHPE, 3 mol% NBD-DHPE) were included to allow assays of lipid
dequenching. Molar protein:lipid ratios were 1:1,000–1:10,000 for SNAREs and
1:2,000–1:10,000 for Ypt7, which was present on all proteoliposomes used in
this study. Isolation after reconstitution was achieved by floatation on a three-
step Histodenz gradient [35%, 25% Histodenz (wt/vol), and RB150/Mg2+].
Reconstituted Proteoliposome Fusion Assays. Fusion reactions were assembled
in 20 μL. Fusion assay pairs of reconstituted proteoliposomes (RPLs) (each 250
μM lipid) in RB150, 5 μM streptavidin, 1 mM EDTA, and 10 μM GTP were
preincubated for 10 min at 27 °C before addition of 1.25 mM MgCl2 to ex-
change Ypt7 to its GTP-bound form, and then 10 μL was transferred to wells
of 384-well plates. Soluble components (10 μL; e.g., HOPS, Sec17, Sec18, ATP,
sVti1, Vam7) or their respective buffers were added to initiate the reactions,
either as one addition or two consecutive 5-μL additions. All reactions con-
tained 0.5% (wt/vol) defatted BSA, 5 mM reduced glutathione, and 1 mM
DTT. Plates were incubated at 27 °C in a fluorescence plate reader for 30
min, and content mixing signals [PhycoE–Cy5-FRET: excitation (ex): 565 nm;
emission (em): 670 nm; cutoff: 630 nm] were recorded at intervals of 10–30 s
in a SpectraMax Gemini XPS (Molecular Devices) fluorescence plate reader.
Maximal values were determined after addition of 0.1% (wt/vol) Thesit to
samples that had not received streptavidin.
Determination of trans-SNARE Associations by Coimmunoprecipitation. To es-
timate the amount of trans-SNARE association that formed during a reaction,
the amount of Nyv1 that coimmunoprecipitated with Vam3 was determined.
A 40-μL fusion reaction was incubated for 2 min at 27 °C, placed on ice, and
diluted 10-fold in ice-cold RIPA buffer [20 mM Hepes·NaOH, pH 7.4, 150 mM
NaCl, 0.2% (wt/vol) BSA, 1% (vol/vol) Triton X-100, 1% (wt/vol) sodium cholate,
0.1% (wt/vol) SDS] containing 50 μg/mL affinity-purified anti-Vam3 antibody
and 10 μM GST-Nyv1. After 20 μL RIPA buffer-washed protein A magnetic
beads (Thermo Scientific) was added, the mix was nutated at room tempera-
ture for 2 h. After the beads were washed three times with 1 mL of RIPA
buffer, samples were eluted in 50 μL of reducing SDS sample buffer at 95 °C for
5 min. Aliquots (20 μL) of each sample were subjected to SDS/PAGE and im-
munoblotting with anti-Nyv1 antibody.
Sec17 and Soluble SNARE Membrane Binding Assay. Liposomes composed of
83.5 mol% DLPC, 15 mol% DLPS, and 1.5 mol% NBD-DHPE were prepared by
detergent dialysis. Liposomes in RB150/Mg2+ were mixed with BSA, a mixture
of either the four soluble SNAREs or their buffers, and Sec17. Final con-
centrations were 0.5 mM lipid, 0.2% (wt/vol) BSA, 2 μM each SNARE, and
1 μM Sec17 in 32 μL per reaction. Reactions were gently vortexed, incubated
at 30 °C for 1 h, and placed on ice for 5 min. Histodenz [96 μL of a 54% (wt/vol)
solution in isoosmolar RB150/Mg2+ containing just 2% (vol/vol) glycerol] was
added. Tubes were vortexed gently. Samples (80 μL) were transferred to 7- ×
20-mm polycarbonate centrifuge tubes (Beckman Coulter), overlaid with 80 μL
of 35% (wt/vol) and then 80 μL of 30% (wt/vol) isoosmolar Histodenz in
RB150/Mg2+, and finally with 50 μL of RB150/Mg2+. The remaining sample
was solubilized in 0.1% (vol/vol) Thesit for lipid recovery determination. Tubes
were centrifuged in a TLS55 rotor (Beckman Coulter) for 1.5 h at 55,000 rpm
and 4 °C. Floated liposomes (80 μL) were harvested from the top of the tube
and solubilized in 0.1% (vol/vol) Thesit. Lipid recovery was determined by
measuring NBD fluorescence (ex: 460 nm; em: 538 nm; cutoff: 515 nm) of the
starting samples vs. the floated samples. Floated samples and starting samples
were incubated in SDS sample buffer for 5 min at 90 °C and then analyzed by
SDS/PAGE, followed by immunoblotting. The sample volumes that were
loaded were adjusted according to lipid recovery. Serial twofold dilutions of
the starting sample provided a standard curve for quantifying the amount of
bound protein using UN-SCAN-IT software (Silk Scientific).
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